Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$9.3 - $18.27 $988,208 - $1.94 Million
-106,259 Reduced 86.94%
15,969 $155,000
Q2 2022

Aug 15, 2022

BUY
$11.79 - $27.63 $1.44 Million - $3.38 Million
122,228 New
122,228 $1.77 Million
Q4 2021

Feb 14, 2022

SELL
$36.68 - $54.02 $2.69 Million - $3.96 Million
-73,321 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$49.57 - $58.15 $3.63 Million - $4.26 Million
73,321 New
73,321 $3.67 Million
Q2 2021

Aug 13, 2021

SELL
$47.17 - $58.64 $25.7 Million - $31.9 Million
-544,171 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$42.51 - $54.07 $16.4 Million - $20.9 Million
-386,015 Reduced 41.5%
544,171 $25.5 Million
Q4 2020

Feb 16, 2021

BUY
$31.9 - $44.89 $2.25 Million - $3.16 Million
70,456 Added 8.2%
930,186 $40.5 Million
Q3 2020

Nov 16, 2020

SELL
$28.55 - $36.91 $1.54 Million - $1.99 Million
-54,023 Reduced 5.91%
859,730 $31.5 Million
Q2 2020

Aug 13, 2020

SELL
$24.0 - $32.87 $2.56 Million - $3.5 Million
-106,605 Reduced 10.45%
913,753 $26.7 Million
Q1 2020

May 15, 2020

BUY
$17.8 - $37.6 $18.2 Million - $38.4 Million
1,020,358 New
1,020,358 $26.7 Million

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $378M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.